Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

66.7%

-19.9% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 3

3(60.0%)

N/A

2(40.0%)

5Total

Phase 3(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06564974Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

Role: collaborator

NCT07637734Phase 3Not Yet Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

Role: collaborator

NCT07457918Phase 3Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Role: collaborator

NCT07246590Phase 3Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Role: collaborator

NCT05516940Completed

A Study of the Impact of Different Delivery Modes on Specific Macronutrient Components in Human Milk

Role: collaborator

NCT05160675Completed

Nutrition, Microbiome and Bone Health During Early Life Related to Health

Role: collaborator

NCT04880083Not ApplicableCompleted

Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein

Role: collaborator

NCT04763512Not ApplicableCompleted

Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

Role: collaborator

NCT04787926Terminated

DuraLock-C Catheter Lock Solution

Role: collaborator

NCT04782297Withdrawn

Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)

Role: collaborator

All 10 trials loaded